Protein-ligand binding affinity prediction: Is 3D binding pose needed?

Ming-Hsiu Wu,Ziqian Xie,Degui Zhi
DOI: https://doi.org/10.1101/2024.04.16.589805
2024-09-18
Abstract:Accurate protein-ligand binding affinity prediction is crucial in drug discovery. Existing methods are predominately docking-free, without explicitly considering atom-level interaction between proteins and ligands in scenarios where crystallized protein-ligand binding conformations are unavailable. Now, with breakthroughs in deep learning AI-based protein folding and binding conformation prediction, can we improve binding affinity prediction? This study introduces a framework, Folding-Docking-Affinity (FDA), which folds proteins, determines protein-ligand binding conformations, and predicts binding affinities from three-dimensional protein-ligand binding structures. Our experiments demonstrate the feasibility of our FDA framework and its superiority over state-of-the-art docking-free models, showcasing the potential of explicit modeling of three-dimensional binding conformations for enhancing binding affinity prediction accuracy.
Bioinformatics
What problem does this paper attempt to address?
The paper aims to address the problem of predicting the binding affinity between proteins and small molecule ligands. Specifically, the study explores whether docking-based methods can outperform non-docking methods that do not consider atomic-level interactions in the absence of high-resolution binding structures. To achieve this goal, the authors propose a new framework called Folding-Docking-Affinity (FDA), which consists of three parts: 1. **Folding**: Generating 3D protein structures from amino acid sequences. 2. **Docking**: Docking ligands onto the generated protein structures. 3. **Affinity Prediction**: Predicting binding affinity from the computed 3D protein-ligand binding structures. Through experimental validation, the FDA framework outperforms existing non-docking methods on two public datasets, DAVIS and KIBA, especially when dealing with unseen protein and drug combinations. Additionally, the authors conducted ablation studies to analyze the impact of biases introduced by ColabFold and DiffDock on the final affinity prediction results. They found that structures generated using ColabFold combined with DiffDock's docking approach sometimes even outperformed methods using crystal structures. These findings suggest that AI-based protein folding and docking methods can significantly improve the accuracy of binding affinity predictions in the absence of high-resolution crystal structures.